Cart
sales@molnova.com
ASP7663
CAS No. 1190217-35-6
ASP7663 ( —— )
Catalog No. M21597 CAS No. 1190217-35-6
ASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 51 | Get Quote |
|
| 5MG | 77 | Get Quote |
|
| 10MG | 120 | Get Quote |
|
| 25MG | 222 | Get Quote |
|
| 50MG | 354 | Get Quote |
|
| 100MG | 514 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameASP7663
-
NoteResearch use only not for human use.
-
Brief DescriptionASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
-
DescriptionASP7663 is a?TRPA1 Receptor Agonist?and exhibiting an abdominal analgesic effect in vivo.?
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRPA1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1190217-35-6
-
Formula Weight263.26
-
Molecular FormulaC14H14FNO3?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(C)CN1C(=O)\C(=C\C(O)=O)c2cccc(F)c12
-
Chemical Name(2E)-2-[7-Fluoro-12-dihydro-1-(2-methylpropyl)-2-oxo-3H-indol-3-ylidene]acetic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Kojima R Nozawa K Doihara H et al. Effects of novel TRPA1 receptor agonist ASP7663 in models of drug-induced constipation and visceral pain[J]. European Journal of Pharmacology 2014 723:288-293.
molnova catalog
related products
-
L-R4W2
Vanilloid TRPV1 (VR1) receptor antagonist peptide (IC50 ~ 0.1 μM); blocks Ca2+ currents in dorsal root ganglion neurons. Analgesic in vivo.
-
N-Ethyl-p-menthane-3...
N-Ethyl-p-menthane-3-carboxamide is an agonist of TRPM8( EC50 : 3.7 μM).
-
EIPA
EIPA (L593754, MH 12-43) is a TRPP3 channel inhibitor (IC50: 10.5 μM). It also inhibits Na+/H+-exchanger (NHE) and macropinocytosis.It is found that EIPA, benzamil, and phenamil rapidly and reversibly block Ca2+-activated TRPP3 channel activation at -50 mV, with IC50s of 143, 10.5, 1.1, and 0.14 μM, respectively.
